Perspective: Research highlights at the gladstone institute of virology and immunology unraveling the function of hiv type 1 nef

AIDS Research and Human Retroviruses

Volumn 12, Issue 17, 1996, Pages 1579-1582

  Geleziunas, Romas ^a   Miller, Michael D ^b   Greene, Warner C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NEF PROTEIN; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; DOWN REGULATION; HUMAN; IMMUNOLOGY; LENTIVIRINAE; PATHOGENICITY;

ANIMALS; ANTIGENS, CD4; DOWN-REGULATION; GENE PRODUCTS, NEF; HIV-1; HUMANS; LENTIVIRUS; SIGNAL TRANSDUCTION;

EID: 0030445915     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1579     Document Type: Article

References (31)

1. Kestler H, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, and Desrosiers RC Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991;65:651-662.
2. Jamieson BD, Aldrovandi G, Planelles V, Jowett JBM, Gao L, Bloch LM, Chen ISY, and Zack JA Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol 1994;68:3478-3485.
3. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, and Mills J Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-991.
4. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, and Desrosiers RC Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995;332:228-232.
5. Miller MD, Warmerdam MT, Gaston I, Greene WC, and Feinberg MB The HIV-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994;179:101-113.
6. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, and Richman DD The importance of Nef in the induction of HIV-1 replication from primary quiescent CD4 lymphocytes. J Exp Med 1994;179:115-123.
7. Chowers MY, Spina CA, Kwoh TJ, Fitch NJS, Richman DD, and Guatelli JC Optimal infectivity in vitro of HIV-1 requires an intact nef gene. J Virol 1994;68:2906-2914.
8. Miller MD, Warmerdam MT, Page KA, Feinberg MB, and Greene WC Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J Virol 1995;69:570-584.
9. Aiken C and Trono D Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol 1995;69:5048-5056.
10. Pandori MW, Fitch NJS, Craig HM, Richman DD, Spina CA, and Guatelli JC Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J Virol 1996;70:4283-4290.
11. Welker R, Kottler H, Kalbitzer HR, and Krausslich HG Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 1996;219:228-236.
12. Gaedigk-Nitschko K, Schon A, Wachinger G, Erfle V, and Kohleisen B Cleavage of recombinant and cell derived HIV-1 Nef protein by HIV-1 protease. FEBS Lett 1995;357:275-278.
13. Schwartz O, Marechal V, Danos O, and Heard JM Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J Virol 1995;69:93-100.
14. Aiken C, Konner J, Landau NR, Lenburg ME, and Trono D Nef induces CD4 endocytosis: Requirement for a critical motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994;76:853-864.
15. Garcia JV, Alfano J, and Miller AD The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. J Virol 1993;67:1511-1516.
16. Dietrich J, Hou X, Wegener AMK, and Geisler C CD3γ contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J 1994;13:2156-2166.
17. Goldsmith MA, Warmerdam MT, Atchison RE, Miller MD, and Greene WC Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J Virol 1995;69:4112-4121.
18. Benson RE, Sanfridson A, Ottinger JS, Doyle C, and Cullen BR Downregulation of cell-surface CD4 expression by SIV Nef prevents viral superinfection. J Exp Med 1993;177:1561-1566.
19. Saksela K, Cheng G, and Baltimore D Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 1995;14:484-491.
20. Sawai ET, Baur A, Struble H, Peterlin BM, Levy JA, and Cheng-Mayer C Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc Natl Acad Sci USA 1994;91:1539-1543.
21. Sawai ET, Baur AS, Peterlin BM, Levy JA, and Cheng MC A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J Biol Chem 1995;270:15307-14.
22. Baur SB, Sawai ET, Dazin P, Fantl WJ, Cheng-Mayer C, and Peterlin BM HTV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1994;1:373-384.
23. De SK and Marsh JW HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. J Biol Chem 1994;269:6656-6660.
24. Graziani A, Galimi F, Medico E, Cottone E, Gramaglia D, Boccaccio C, and Comoglio PM The HIV-1 Nef protein interferes with phosphatidylinositol 3-kinase activation. 1. J Biol Chem 1996;271:6590-6593.
25. Brady HJM, Pennington DJ, Miles CG, and Dzierzak EA CD4 cell surface down-regulation of HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J 1993;12:4923-4932.
26. Lindemann D, Wilhelm R, Renard P, Althage A, Zinkernagel R, and Mous J Severe immunodeficiency associated with an HIV-1 Nef/3′ LTR transgene. J Exp Med 1994;179:797-807.
27. Collette Y, Chang H-L, Cerdan C, Chambost H, Algarte M, Mawas C, Imbert J, Burny A, and Olive D Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 nef gene-induced expression. J Immunol 1996;156:360-370.
28. Luria S, Chambers I, and Berg P Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci USA 1991;88:5326-5330.
29. Benveniste O, Vaslin B, Le Grand R, Cheret A, Matheux F, Theodore F, Cranage MP, and Dormont D Comparative interleukin (IL)-2/interferon (IFN)-γ and IL-4/IL-10 responses during acute infection or macaques inoculated with attenuated nef-truncated or pathogenic SIVmac215 virus. Proc Natl Acad Sci USA 1996;93:3658-3663.
30. Skowronski J, Parks D, and Mariani R Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J 1993;12:703-713.
31. Du Z, Lang SB, Sasseville VG, Lackner AA, Ilyinskii PO, Daniel MD, Jung JU, and Desrosiers RC Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 1995;82:665-674.